{"favorite_id": 3822, "calc_type": "calculator", "dosing": false, "full_title_en": "TNM Staging for Hepatocellular Carcinoma (HCC)", "short_title_en": "TNM HCC Staging", "medium_description_en": "Stages HCC based on tumor, lymph nodes, and metastases.", "short_description_en": "HCC staging.", "before_use": "", "instructions_en": "<p>This calculator is based on the 7th edition of the AJCC Cancer Staging Manual. The <calculator id=\"10116\">8th edition</calculator> is now recommended for use over this version.</p>", "purpose_en": ["Prognosis"], "disease_en": ["Cancer", "Chemotherapy", "Cirrhosis", "Hepatocellular Carcinoma"], "specialty_en": ["Gastroenterology", "Hematology and Oncology", "Hepatology", "Hospitalist Medicine", "Internal Medicine", "Surgery (General)"], "chief_complaint_en": ["Abdominal Pain", "Weakness"], "system_en": ["Gastrointestinal"], "search_abbreviation_en": ["hcc"], "slug": "tnm-staging-hepatocellular-carcinoma-hcc", "seo": {"meta_description_en": "The TNM Staging for Hepatocellular Carcinoma (HCC) stages hepatocellular carcinoma based on tumor, lymph node, and metastasis characteristics.", "keywords_en": "TNM Staging for hepatocellular cancer, hepatocellular cancer, hepatocellular ca, pancreas cancer, pancreas ca, panc ca tnm, hepatocellular cancer tnm, hepatocaellular cancer staging, hepatocaellular, ca, cancer, carcinoma, hcc, liver, chronic, prognosis"}, "content": {"how_to_use": {"use_case_en": "<p>Patients diagnosed with hepatocellular carcinoma (HCC) who have undergone surgical resection.</p>", "pearls_pitfalls_en": "<ul> <li>Stages HCC by tumor, nodes, and metastasis characteristics.</li> <li>Requires pathologic specimen for evaluation, thus limiting its use since most HCC patients do not undergo surgical resection.</li> <li>Does not account for liver function, which is a known prognostic factor in HCC and cirrhosis.</li> </ul>", "why_use_en": "<ul> <li>Gives prognosis of HCC when pathologic data is available.</li> <li>Barcelona Clinic Liver Cancer (BCLC) staging may be more clinically useful, as it incorporates liver function and patient functional status, and does not require a pathologic specimen.</li> </ul>"}, "next_steps": {"advice_en": "<ul> <li>National Comprehensive Cancer Network (NCCN) guidelines use TNM staging for treatment recommendations, but note that many staging systems exist, all have limitations, and some are region-dependent.</li> <li>Can only be used if patient has had surgical resection.</li> </ul>", "management_en": "", "critical_actions_en": ""}, "about": {"formula_en": "<p>Staging based on multiple factors including:</p> <ul> <li>Primary tumor (T) characteristics</li> <li>Regional lymph nodes (N) <ul> <li>Clinical</li> <li>Pathological</li> </ul> </li> <li>Distant metastasis (M)</li> </ul>", "more_info_en": "<table> <tbody> <tr> <th>Stage</th> <th>T</th> <th>N</th> <th>M</th> </tr> <tr> <td>I</td> <td>T1</td> <td>N0</td> <td>M0</td> </tr> <tr> <td>II</td> <td>T2</td> <td>N0</td> <td>M0</td> </tr> <tr> <td>IIIA</td> <td>T3a</td> <td>N0</td> <td>M0</td> </tr> <tr> <td>IIIB</td> <td>T3b</td> <td>N0</td> <td>M0</td> </tr> <tr> <td>IIIC</td> <td>T4</td> <td>N0</td> <td>M0</td> </tr> <tr> <td>IVA</td> <td>Any T</td> <td>N1</td> <td>M0</td> </tr> <tr> <td>IVB</td> <td>Any T</td> <td>Any N</td> <td>M1</td> </tr> </tbody> </table> <p>Survival by stage, from Kee&nbsp;et al, 2013:</p> <table> <tbody> <tr> <td rowspan=\"2\"><strong>Stage</strong></td> <td colspan=\"2\"><strong>5-year survival</strong></td> </tr> <tr> <td><strong>With treatment</strong></td> <td><strong>Without treatment</strong></td> </tr> <tr> <td>I</td> <td>37.9%</td> <td>9.4%</td> </tr> <tr> <td>II</td> <td>36.1%</td> <td>7.3%</td> </tr> <tr> <td>IIIA</td> <td>26.3%</td> <td>6.6%</td> </tr> <tr> <td>IIIB</td> <td>18.8%</td> <td>6.0%</td> </tr> <tr> <td>IIIC</td> <td>29.1%</td> <td>14.3%</td> </tr> <tr> <td>IVA</td> <td>28.6%</td> <td>20.0%</td> </tr> <tr> <td>IVB</td> <td>20.9%</td> <td>17.1%</td> </tr> </tbody> </table>", "evidence_based_medicine_en": "<ul> <li>The TNM staging system for HCC, like all TNM staging systems, was developed by the American Joint Committee on Cancer (AJCC).</li> <li>The data have been validated with prospective data from 8,828 patients <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/23703450\">(Kee 2013)</a>, showing significant differences in survival among stages.&nbsp;</li> </ul> <p>&nbsp;</p> <p>&nbsp;</p>", "references_list": {"Original/Primary Reference": [{"text": "Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, et al. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer-Verlag; 2010."}], "Other References": [{"href": "", "text": ""}], "Validation": [{"href": "https://www.ncbi.nlm.nih.gov/pubmed/23703450", "text": "Kee KM, Wang JH, Lin CY, Wang CC, Cheng YF, Lu SN. Validation of the 7th edition TNM staging system for hepatocellular carcinoma: an analysis of 8,828 patients in a single medical center. Dig Dis Sci. 2013 Sep;58(9):2721-8. doi: 10.1007/s10620-013-2716-8. Epub 2013 May 24."}, {"href": "https://www.ncbi.nlm.nih.gov/pubmed/17304512", "text": "Kee KM, Wang JH, Lee CM, Chen CL, Changchien CS, Hu TH, Cheng YF, Hsu HC, Wang CC, Chen TY, Lin CY, Lu SN. Validation of clinical AJCC/UICC TNM staging system for hepatocellular carcinoma: analysis of 5,613 cases from a medical center in southern Taiwan. Int J Cancer. 2007 Jun 15;120(12):2650-5."}], "Clinical Practice Guidelines": [{"href": "https://www.nccn.org/professionals/physician_gls/f_guidelines.asp", "text": "National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology. Hepatobiliary Cancers Version 2.2016. 2016 Jun 27;National Comprehensive Cancer Network."}], "Manufacturer Website": [{"href": "", "text": ""}], "Outcomes": [{"href": "", "text": ""}]}}, "contributor": {"expert_name": []}, "reviewer": {"expert_name": []}, "creator": [{"name": "Dr. Stephen Edge", "creator_info": {"about_en": "<p>Stephen B. Edge, MD, FACS, FASCO, is an adjunct professor of surgery at Vanderbilt University and the current director of the Baptist Cancer Center. Dr. Edge has co-chaired the 2010 Breast Cancer Symposium and Guideline Panel for Postmastectomy Radiation and is serving on the editorial board of the Journal of Oncology Practice. His research focuses on staging systems and risk stratification for many types of cancers.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-stephen-edge.jpeg", "pubmedLink": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Edge+SB%5BAuthor%5D"}}], "related_resources": {"mdcalc_rating": {"evidence": "", "clinical": "", "popularity": ""}, "guidelines": [], "teaching": [], "videos": [], "interests": [], "partner_contact": [], "sdm_tool": []}}, "input_schema": [{"type": "radio", "label_en": "Primary tumor (T)", "name": "t", "options": [{"label": "No evidence of primary tumor", "value": 2}, {"label": "Solitary tumor without vascular invasion", "value": 3}, {"label": "Solitary tumor with vascular invasion or multiple tumors, none > 5 cm", "value": 4}, {"label": "Multiple tumors > 5 cm", "value": 5}, {"label": "Single tumor or multiple tumors of any size involving a major branch of the portal or hepatic vein", "value": 6}, {"label": "Tumor(s) with direct invasion of adjacent organs other than gallbladder or with visceral peritoneum", "value": 7}, {"label": "Primary tumor cannot be assessed", "value": 1}], "conditionality": "", "show_points": false, "optional": false}, {"type": "radio", "label_en": "Regional lymph nodes (N)", "name": "n", "options": [{"label": "No regional lymph node metastasis", "value": 2}, {"label": "Regional lymph node metastasis", "value": 3}, {"label": "Regional lymph nodes cannot be assessed", "value": 1}], "conditionality": "", "show_points": false, "optional": false}, {"type": "radio", "label_en": "Distant metastasis (M)", "name": "m", "options": [{"label": "No distant metastasis", "value": 1}, {"label": "Distant metastasis", "value": 2}], "conditionality": "", "show_points": false, "optional": false}], "md5": "74e4781426dda1d584198aebc0dcae2b", "related_calcs": [{"calcId": 10116, "short_title_en": "TNM HCC Staging (8th Ed.)", "slug": "tnm-staging-hepatocellular-carcinoma-hcc-8th-edition"}, {"calcId": 10052, "short_title_en": "Liver Decompensation Risk", "slug": "liver-decompensation-risk-hepatectomy-hepatocellular-carcinoma-hcc"}, {"calcId": 3900, "short_title_en": "Milan Criteria", "slug": "milan-criteria-liver-transplantation"}]}